Most-Favored-Nation pricing meets Joint Clinical Assessment: early evidence of compounding pressure on European drug launches. [PDF]
Ramagopalan SV, Ryan ML.
europepmc +1 more source
Monitoring outcomes in patients treated by ATMPs. [PDF]
Konstantopoulos K.
europepmc +1 more source
ATMPs prepared under hospital exemption: European Blood Alliance position paper. [PDF]
Domanović D +17 more
europepmc +1 more source
Engineering the future of advanced therapy medicinal products: a bioengineering call to action. [PDF]
Nieri G +4 more
europepmc +1 more source
Thailand's Aging Society: Reconsidering Policy and Innovation Readiness for Elderly Care. [PDF]
Supakul S, Toyoda P.
europepmc +1 more source
Outlook of Cell Gene Therapies Development and Approval from Quality and Regulatory Perspective. [PDF]
Iglesias-Lopez C, Vallano A, Agustí A.
europepmc +1 more source
A decade of clinical trials in Italy (2016-2025): trends, regulatory transformation and biotechnological evolution. [PDF]
De Paola E +3 more
europepmc +1 more source
Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China. [PDF]
Shi J, Hu H, Ung COL.
europepmc +1 more source
Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest link. [PDF]
Chartral U +34 more
europepmc +1 more source
The Landscape of Advanced Therapy Medicinal Products in Slovenian Transfusion Medicine: A Review of Past and Future Outlook. [PDF]
Švajger U +3 more
europepmc +1 more source

